Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 3,004 | 19,635 | 0 | 12,475 | 3,847 |
| Gross Profit | 3,004 | 19,635 | N/A | 12,475 | 3,847 |
| Operating Expenses | 25,622 | 36,915 | 0 | 46,333 | 16,711 |
| Operating Income | -22,618 | -17,280 | N/A | -33,858 | -12,864 |
| Other Income | 2,432 | 647 | 0 | -140,584 | -15 |
| Pre-tax Income | -20,186 | -16,633 | 0 | -174,442 | -12,879 |
| Net Income Continuous | -20,186 | -16,633 | N/A | -174,442 | -12,879 |
| Net Income | $-20,186 | $-16,633 | $N/A | $-174,442 | $-12,879 |
| EPS Basic Total Ops | -1.18 | -0.97 | N/A | N/A | -0.75 |
| EPS Basic Continuous Ops | -1.18 | -0.97 | N/A | N/A | -0.75 |
| EPS Diluted Total Ops | -1.18 | -0.97 | N/A | N/A | -0.75 |
| EPS Diluted Continuous Ops | -1.18 | -0.97 | N/A | N/A | -0.75 |
| EPS Diluted Before Non-Recurring Items | -1.18 | -0.97 | N/A | N/A | N/A |
| EBITDA(a) | $-22,525 | $-17,129 | $N/A | $-33,858 | $-12,785 |